Body composition changes with protease therapy.
Berger
D
D
D000273:Adipose Tissue; D001823:Body Composition; D013006:Growth Hormone / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D019382:Human Growth Hormone; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced* / Q000188:drug therapy; D010074:Oxandrolone / Q000627:therapeutic use*
D017320:HIV Protease Inhibitors; D019382:Human Growth Hormone; D010074:Oxandrolone; D013006:Growth Hormone